Compare SPRO & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRO | IH |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.5M | 116.0M |
| IPO Year | 2017 | 2020 |
| Metric | SPRO | IH |
|---|---|---|
| Price | $2.28 | $1.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 337.6K | 10.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,977,000.00 | N/A |
| Revenue This Year | N/A | $39.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.67 |
| 52 Week High | $3.09 | $3.60 |
| Indicator | SPRO | IH |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 44.42 |
| Support Level | $2.15 | $1.79 |
| Resistance Level | $2.44 | $3.12 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 55.11 | 28.09 |
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.